IceCure Medical Ltd.

ICCM

Healthcare Medical Devices

IceCure Medical Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $3.4 million, up 2.67% from fiscal 2024.

Revenue
−0.69%
EPS
−2,068.2%
Free cash flow
+3.88%
Total debt
−64.4%

Quarter to June 2026, against a year earlier

0.68 0.01 −1.45%
Market cap
$2.3M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
4/9
ROIC
0.00%
Net debt / EBITDA
0.6×
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
— 4 — —

+8 more TTM periods

ROE
0.00% (212.37%) 0.00% 0.00%
ROA
0.00% (126.11%) 0.00% 0.00%
ROIC
0.00% (2,524.58%) 0.00% 0.00%
Return on Tangible Assets
0.00% (185.54%) 0.00% 0.00%
Average Days of Receivables
0.00 37.05 0.00 0.00
Free Cash Flow per Share
0.00 (8.48) — 0.00
Free Cash Flow
(20.63) (20.78) — (24.84)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026